BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 1, 2016
View Archived Issues
MedImmune and Abpro to collaborate in developing bispecific antibody
Read More
Positive interim data of phase II study of inclisiran at 90 days
Read More
Preclinical data on RG-7386 in solid tumors
Read More
CytRx reports updated findings from phase III trial of aldoxorubicin for soft tissue sarcomas
Read More
Voyager Therapeutics exercises options for rights to NAV vectors
Read More
TPC-107, shows high efficacy in cancer tumor mouse models
Read More
A tetravalent vaccine candidate against lymphatic filariasis
Read More
First-in-human trial finds synthetic preimplantation factor safe and well tolerated
Read More
Global Blood Therapeutics' GBT-440 granted orphan designation in E.U.
Read More
Ultragenyx Pharmaceutical reports 78-week data from phase II study of UX-007
Read More
FDA clears IND for KN-035
Read More
Viracta Therapeutics completes acquisition of HDAC inhibitor from Chroma Therapeutics
Read More
Bicycle Therapeutics establishes bicyclic peptide collaboration with AstraZeneca
Read More
BiondVax's universal flu vaccine safe, well tolerated in phase II study
Read More
FDA accepts for review sNDA for expanded label of Abilify Maintena
Read More
FDA grants orphan drug designation to risankizumab
Read More
Chugai files for approval of Actemra for additional indication in Japan
Read More
Naia submits IND application to initiate phase Ib trial of NB-1001 in short bowel syndrome
Read More
Five of ProMIS Neurosciences' MAbs for Alzheimer's block prion-like propagation
Read More
Bioavailability results presented for GSP-301 at ACAAI
Read More
Committee recommends continuation of phase III study of ThermoDox in liver cancer
Read More
MicuRx Pharmaceuticals begins phase I study of MRX-4
Read More
Tangrun Pharmaceuticals patents agents for HCV infection
Read More
Australian institutes describe IRAP inhibitors
Read More
Selvita reports PFKFB inhibitors in patent
Read More
Roche patent describes TLR7 agonists for HBV infections
Read More
Boehringer Ingelheim prepares and tests IGF-1R inhibitors
Read More
